Cellectis S.A. Stock Other OTC
Equities
CMVLF
FR0010425595
Biotechnology & Medical Research
Sales 2024 * | 31.18M 33.57M 46.2M | Sales 2025 * | 50.03M 53.86M 74.14M | Capitalization | 236M 254M 350M |
---|---|---|---|---|---|
Net income 2024 * | -40M -43.06M -59.27M | Net income 2025 * | -66M -71.05M -97.8M | EV / Sales 2024 * | 2.33 x |
Net cash position 2024 * | 163M 176M 242M | Net cash position 2025 * | 88.23M 94.99M 131M | EV / Sales 2025 * | 2.95 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.92% |
Latest transcript on Cellectis S.A.
Managers | Title | Age | Since |
---|---|---|---|
David Sourdive
FOU | Founder | 57 | 99-12-19 |
André Choulika
FOU | Founder | 59 | 99-12-19 |
Arthur Stril
DFI | Director of Finance/CFO | 35 | 18-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 75 | 20-11-04 | |
André Choulika
FOU | Founder | 59 | 99-12-19 |
David Sourdive
FOU | Founder | 57 | 99-12-19 |
1st Jan change | Capi. | |
---|---|---|
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |